Marketing analytics software Semrush (NYSE:SEMR) will be announcing earnings results tomorrow after market close. Here's what you need to know.
Last quarter SEMrush reported revenues of $74.7 million, up 19.3% year on year, in line with analyst expectations. It was a weaker quarter for the company, with underwhelming revenue guidance for the next quarter and decelerating customer growth. The company added 4,000 customers to a total of 104,000.
Is SEMrush buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting SEMrush's revenue to grow 19.7% year on year to $78.7 million, slowing down from the 33.6% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.02 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St's expectations, beating revenue estimates every single time over the past two years on average by 2.37%.
Looking at SEMrush's peers in the sales and marketing software segment, some of them have already reported Q3 earnings results, giving us a hint of what we can expect. VeriSign (NASDAQ:VRSN) delivered top-line growth of 5.44% year on year, missing analyst estimates by 0.75%, and ZoomInfo reported revenues up 9.11% year on year, exceeding estimates by 1.06%. VeriSign traded flat on the results, Zoominfo was up 1.48%.
Read the full analysis of VeriSign's and ZoomInfo's results on StockStory.
Triggered by the Federal Reserve's hawkish stance on interest rates, shares of technology companies have been facing sell-off in 2022, and while some of the sales and marketing software stocks have fared somewhat better, they have not been spared, with share price declining 8.09% over the last month. SEMrush is down 1.94% during the same time, and is heading into the earnings with analyst price target of $12, compared to share price of $8.1.
The author has no position in any of the stocks mentioned.